-
1
-
-
0036606093
-
Diagnosis of osteoporosis and assessment of fracture risk
-
Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929-1936.
-
(2002)
Lancet
, vol.359
, Issue.9321
, pp. 1929-1936
-
-
Kanis, J.A.1
-
2
-
-
14744295128
-
-
National Health and Nutrition Examination Survey Osteoporosis Data Brief 12/02, Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, Cited 2009 Jan 9, Available from
-
National Health and Nutrition Examination Survey Osteoporosis Data Brief 12/02. Osteoporosis. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [Cited 2009 Jan 9.] Available from: http://www.cdc.gov/nchs/ data/nhanes/databriefs/osteoporosis.pdf
-
Osteoporosis
-
-
-
3
-
-
0028968710
-
Prevalence of low femoral bone density in older US women from NHANES III
-
Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res. 1995;10(5):796-802.
-
(1995)
J Bone Miner Res
, vol.10
, Issue.5
, pp. 796-802
-
-
Looker, A.C.1
Johnston Jr, C.C.2
Wahner, H.W.3
-
4
-
-
33748267772
-
-
US Government Printing Office, Washington, DC
-
He W, Manisha Sengupta, Vicotoria A. Velkoff, and Kimberly A. DeBarrows, US Census Bureau, Current Population Reports, P-23-209, 65+ in the United States: 2005, US Government Printing Office, Washington, DC, 2005.
-
(2005)
DeBarrows, US Census Bureau, Current Population Reports, P-23-209, 65+ in the United States
-
-
He, W.1
Sengupta, M.2
Vicotoria, A.3
Velkoff4
Kimberly, A.5
-
5
-
-
66349086841
-
-
Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC: National Osteoporosis Foundation; c2008 [updated 2008 Feb 21; cited 2009 Jan 9]. Available from: http://www.nof.org/professionals/ NOF_Clinicians_Guide.pdf.
-
Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC: National Osteoporosis Foundation; c2008 [updated 2008 Feb 21; cited 2009 Jan 9]. Available from: http://www.nof.org/professionals/ NOF_Clinicians_Guide.pdf.
-
-
-
-
6
-
-
66349131420
-
-
Facts and statistics about osteoporosis and its impact, c, cited 2009 Jan 9. Available from
-
Facts and statistics about osteoporosis and its impact. International Osteoporosis Foundation; c 1999-2007; cited 2009 Jan 9. Available from: http://www.iofbonehealth.org/facts-and-statistics.html.
-
International Osteoporosis Foundation
, vol.1999-2007
-
-
-
7
-
-
0026515737
-
-
Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221-227.
-
Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221-227.
-
-
-
-
8
-
-
0028963682
-
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
-
Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767-773.
-
(1995)
N Engl J Med
, vol.332
, Issue.12
, pp. 767-773
-
-
Cummings, S.R.1
Nevitt, M.C.2
Browner, W.S.3
-
9
-
-
0025357992
-
Hip fracture incidence among the old and very old: A population-based study of 745,435 cases
-
Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health. 1990;80(7):871-873.
-
(1990)
Am J Public Health
, vol.80
, Issue.7
, pp. 871-873
-
-
Jacobsen, S.J.1
Goldberg, J.2
Miles, T.P.3
Brody, J.A.4
Stiers, W.5
Rimm, A.A.6
-
10
-
-
34247395303
-
National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data
-
Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2006;(162):1-209.
-
(2006)
Vital Health Stat
, vol.13
, Issue.162
, pp. 1-209
-
-
Kozak, L.J.1
DeFrances, C.J.2
Hall, M.J.3
-
11
-
-
0030987859
-
The effect of hip fracture on mortality, hospitalization, and functional status: A prospective study
-
Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997;87(3):398-403.
-
(1997)
Am J Public Health
, vol.87
, Issue.3
, pp. 398-403
-
-
Wolinsky, F.D.1
Fitzgerald, J.F.2
Stump, T.E.3
-
12
-
-
0036799693
-
Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study
-
Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50(10):1644-1650.
-
(2002)
J Am Geriatr Soc
, vol.50
, Issue.10
, pp. 1644-1650
-
-
Leibson, C.L.1
Tosteson, A.N.2
Gabriel, S.E.3
Ransom, J.E.4
Melton, L.J.5
-
13
-
-
0029052801
-
Late physical and functional effects of osteoporotic fracture in women: The Rancho Bernardo Study
-
Greendale GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Geriatr Soc. 1995;43(9):955-961.
-
(1995)
J Am Geriatr Soc
, vol.43
, Issue.9
, pp. 955-961
-
-
Greendale, G.A.1
Barrett-Connor, E.2
Ingles, S.3
Haile, R.4
-
14
-
-
0033553866
-
Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group
-
Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159(11):1215-1220.
-
(1999)
Arch Intern Med
, vol.159
, Issue.11
, pp. 1215-1220
-
-
Kado, D.M.1
Browner, W.S.2
Palermo, L.3
Nevitt, M.C.4
Genant, H.K.5
Cummings, S.R.6
-
15
-
-
1342268230
-
Mortality after osteoporotic fractures
-
Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38-42.
-
(2004)
Osteoporos Int
, vol.15
, Issue.1
, pp. 38-42
-
-
Johnell, O.1
Kanis, J.A.2
Oden, A.3
-
16
-
-
0030668668
-
Excess mortality attributable to hip fracture in white women aged 70 years and older
-
Magaziner J, Lydick E, Hawkes W, et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health. 1997;87(10):1630-1636.
-
(1997)
Am J Public Health
, vol.87
, Issue.10
, pp. 1630-1636
-
-
Magaziner, J.1
Lydick, E.2
Hawkes, W.3
-
17
-
-
0036712959
-
Survival and potential years of life lost after hip fracture in men and age-matched women
-
Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int. 2002;13(9):731-737.
-
(2002)
Osteoporos Int
, vol.13
, Issue.9
, pp. 731-737
-
-
Trombetti, A.1
Herrmann, F.2
Hoffmeyer, P.3
Schurch, M.A.4
Bonjour, J.P.5
Rizzoli, R.6
-
18
-
-
0033885229
-
Treatment of osteoporosis: Are physicians missing an opportunity?
-
Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000;82-A(8):1063-1070.
-
(2000)
J Bone Joint Surg Am
, vol.82-A
, Issue.8
, pp. 1063-1070
-
-
Freedman, K.B.1
Kaplan, F.S.2
Bilker, W.B.3
Strom, B.L.4
Lowe, R.A.5
-
19
-
-
44349159586
-
Osteoporosis medication use in nursing home patients with fractures in 1 US state
-
Parikh S, Mogun H, Avorn J, Solomon DH. Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch Intern Med. 2008;168(10):1111-1115.
-
(2008)
Arch Intern Med
, vol.168
, Issue.10
, pp. 1111-1115
-
-
Parikh, S.1
Mogun, H.2
Avorn, J.3
Solomon, D.H.4
-
20
-
-
27144523508
-
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women
-
Perreault S, Dragomir A, Desgagne A, et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf. 2005;14(10):685-695.
-
(2005)
Pharmacoepidemiol Drug Saf
, vol.14
, Issue.10
, pp. 685-695
-
-
Perreault, S.1
Dragomir, A.2
Desgagne, A.3
-
21
-
-
0037394055
-
Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures
-
Neuner JM, Zimmer JK, Hamel MB. Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures. J Am Geriatr Soc. 2003;51(4):483-491.
-
(2003)
J Am Geriatr Soc
, vol.51
, Issue.4
, pp. 483-491
-
-
Neuner, J.M.1
Zimmer, J.K.2
Hamel, M.B.3
-
22
-
-
25144508085
-
Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers
-
Jachna CM, Shireman TI, Whittle J, Ellerbeck EF, Rigler SK. Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. J Am Geriatr Soc. 2005;53(8):1275-1281.
-
(2005)
J Am Geriatr Soc
, vol.53
, Issue.8
, pp. 1275-1281
-
-
Jachna, C.M.1
Shireman, T.I.2
Whittle, J.3
Ellerbeck, E.F.4
Rigler, S.K.5
-
23
-
-
33847637558
-
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture
-
Colon-Emeric C, Lyles KW, Levine DA, et al. Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int. 2007;18(4):553-559.
-
(2007)
Osteoporos Int
, vol.18
, Issue.4
, pp. 553-559
-
-
Colon-Emeric, C.1
Lyles, K.W.2
Levine, D.A.3
-
24
-
-
34548425595
-
Use of osteoporosis medications in older nursing facility residents
-
Wright RM. Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc. 2007;8(7):453-457.
-
(2007)
J Am Med Dir Assoc
, vol.8
, Issue.7
, pp. 453-457
-
-
Wright, R.M.1
-
25
-
-
28644439896
-
Determinants of skeletal fragility
-
Bouxsein ML. Determinants of skeletal fragility. Best Pract Res Clin Rheumatol. 2005;19(6):897-911.
-
(2005)
Best Pract Res Clin Rheumatol
, vol.19
, Issue.6
, pp. 897-911
-
-
Bouxsein, M.L.1
-
26
-
-
28644444136
-
What is the role of falls?
-
Close JC, Lord SL, Menz HB, Sherrington C. What is the role of falls? Best Pract Res Clin Rheumatol. 2005;19(6):913-935.
-
(2005)
Best Pract Res Clin Rheumatol
, vol.19
, Issue.6
, pp. 913-935
-
-
Close, J.C.1
Lord, S.L.2
Menz, H.B.3
Sherrington, C.4
-
27
-
-
11844268149
-
Increased falling as a risk factor for fracture among older women: The study of osteoporotic fractures
-
Schwartz AV, Nevitt MC, Brown BW, Jr, Kelsey JL. Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures. Am J Epidemiol. 2005;161(2):180-185.
-
(2005)
Am J Epidemiol
, vol.161
, Issue.2
, pp. 180-185
-
-
Schwartz, A.V.1
Nevitt, M.C.2
Brown Jr, B.W.3
Kelsey, J.L.4
-
28
-
-
34047113324
-
Infl uence of fall related factors and bone strength on fracture risk in the frail elderly
-
Sambrook PN, Cameron ID, Chen JS, et al. Infl uence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int. 2007;18(5):603-610.
-
(2007)
Osteoporos Int
, vol.18
, Issue.5
, pp. 603-610
-
-
Sambrook, P.N.1
Cameron, I.D.2
Chen, J.S.3
-
29
-
-
66349137742
-
-
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. (2006) [updated 2008 Nov 18; cited 2009 Jan 9]. Available from: www.cdc.gov/ncipc/wisqars.
-
Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. (2006) [updated 2008 Nov 18; cited 2009 Jan 9]. Available from: www.cdc.gov/ncipc/wisqars.
-
-
-
-
30
-
-
0025727281
-
Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group
-
Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991;324(19):1326-1331.
-
(1991)
N Engl J Med
, vol.324
, Issue.19
, pp. 1326-1331
-
-
Grisso, J.A.1
Kelsey, J.L.2
Strom, B.L.3
-
31
-
-
33847249451
-
Risk factors associated with the occurrence of fractures in US nursing homes: Resident and facility characteristics and prescription medications
-
Spector W, Shaffer T, Potter DE, Correa-de-Araujo R, Rhona Limcangco M. Risk factors associated with the occurrence of fractures in US nursing homes: resident and facility characteristics and prescription medications. J Am Geriatr Soc. 2007;55(3):327-333.
-
(2007)
J Am Geriatr Soc
, vol.55
, Issue.3
, pp. 327-333
-
-
Spector, W.1
Shaffer, T.2
Potter, D.E.3
Correa-de-Araujo, R.4
Rhona Limcangco, M.5
-
32
-
-
0031972975
-
Epidemiology of medication-related falls and fractures in the elderly
-
Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging. 1998;12(1):43-53.
-
(1998)
Drugs Aging
, vol.12
, Issue.1
, pp. 43-53
-
-
Cumming, R.G.1
-
33
-
-
0035544371
-
Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly
-
Wei TS, Hu CH, Wang SH, Hwang KL. Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly. Osteoporos Int. 2001;12(12):1050-1055.
-
(2001)
Osteoporos Int
, vol.12
, Issue.12
, pp. 1050-1055
-
-
Wei, T.S.1
Hu, C.H.2
Wang, S.H.3
Hwang, K.L.4
-
34
-
-
0027515204
-
Type of fall and risk of hip and wrist fractures: The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group
-
Nevitt MC, Cummings SR. Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 1993;41(11): 1226-1234.
-
(1993)
J Am Geriatr Soc
, vol.41
, Issue.11
, pp. 1226-1234
-
-
Nevitt, M.C.1
Cummings, S.R.2
-
35
-
-
34447514029
-
Vitamin D deficiency
-
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
-
(2007)
N Engl J Med
, vol.357
, Issue.3
, pp. 266-281
-
-
Holick, M.F.1
-
36
-
-
33846693086
-
Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D
-
Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc. 2007;8(2):71-75.
-
(2007)
J Am Med Dir Assoc
, vol.8
, Issue.2
, pp. 71-75
-
-
Hamid, Z.1
Riggs, A.2
Spencer, T.3
Redman, C.4
Bodenner, D.5
-
37
-
-
34547120443
-
Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado
-
Linnebur SA, Vondracek SF, Vande Griend JP, Ruscin JM, McDermott MT. Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother. 2007;5(1):1-8.
-
(2007)
Am J Geriatr Pharmacother
, vol.5
, Issue.1
, pp. 1-8
-
-
Linnebur, S.A.1
Vondracek, S.F.2
Vande Griend, J.P.3
Ruscin, J.M.4
McDermott, M.T.5
-
38
-
-
0034889433
-
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
-
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477-501.
-
(2001)
Endocr Rev
, vol.22
, Issue.4
, pp. 477-501
-
-
Lips, P.1
-
39
-
-
0032796638
-
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
-
Sahota O, Masud T, San P, Hosking DJ. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf). 1999;51(2):217-221.
-
(1999)
Clin Endocrinol (Oxf)
, vol.51
, Issue.2
, pp. 217-221
-
-
Sahota, O.1
Masud, T.2
San, P.3
Hosking, D.J.4
-
40
-
-
0036201198
-
Vitamin D deficiency, muscle function, and falls in elderly people
-
Janssen HCJP, Samson MM, Verhaar HJJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002;75(4): 611-615.
-
(2002)
Am J Clin Nutr
, vol.75
, Issue.4
, pp. 611-615
-
-
Janssen, H.C.J.P.1
Samson, M.M.2
Verhaar, H.J.J.3
-
41
-
-
0032827408
-
Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel
-
Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999;47(10):1195-1201.
-
(1999)
J Am Geriatr Soc
, vol.47
, Issue.10
, pp. 1195-1201
-
-
Stein, M.S.1
Wark, J.D.2
Scherer, S.C.3
-
42
-
-
66349103184
-
-
US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General In: Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004:1-436.
-
US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General In: Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004:1-436.
-
-
-
-
43
-
-
30944448208
-
Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women
-
Schousboe JT, Ensrud KE, Nyman JA, Melton LJ, 3rd, Kane RL. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc. 2005;53(10):1697-1704.
-
(2005)
J Am Geriatr Soc
, vol.53
, Issue.10
, pp. 1697-1704
-
-
Schousboe, J.T.1
Ensrud, K.E.2
Nyman, J.A.3
Melton 3rd, L.J.4
Kane, R.L.5
-
44
-
-
34547755634
-
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men
-
Schousboe JT, Taylor BC, Fink HA, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA. 2007;298(6):629-637.
-
(2007)
JAMA
, vol.298
, Issue.6
, pp. 629-637
-
-
Schousboe, J.T.1
Taylor, B.C.2
Fink, H.A.3
-
45
-
-
0037125875
-
Screening for postmenopausal osteoporosis: A review of the evidence for the US Preventive Services Task Force
-
Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(6):529-541.
-
(2002)
Ann Intern Med
, vol.137
, Issue.6
, pp. 529-541
-
-
Nelson, H.D.1
Helfand, M.2
Woolf, S.H.3
Allan, J.D.4
-
46
-
-
44649120398
-
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
-
Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19(4):399-428.
-
(2008)
Osteoporos Int
, vol.19
, Issue.4
, pp. 399-428
-
-
Kanis, J.A.1
Burlet, N.2
Cooper, C.3
-
47
-
-
42649112056
-
-
Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11(1):75-91.
-
Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11(1):75-91.
-
-
-
-
48
-
-
33644658869
-
Bone density testing in older women and its association with patient age
-
Neuner JM, Binkley N, Sparapani RA, Laud PW, Nattinger AB. Bone density testing in older women and its association with patient age. J Am Geriatr Soc. 2006;54(3):485-489.
-
(2006)
J Am Geriatr Soc
, vol.54
, Issue.3
, pp. 485-489
-
-
Neuner, J.M.1
Binkley, N.2
Sparapani, R.A.3
Laud, P.W.4
Nattinger, A.B.5
-
49
-
-
29044435582
-
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
-
King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int. 2005;16(12): 1545-1557.
-
(2005)
Osteoporos Int
, vol.16
, Issue.12
, pp. 1545-1557
-
-
King, A.B.1
Saag, K.G.2
Burge, R.T.3
Pisu, M.4
Goel, N.5
-
50
-
-
46249101901
-
Longitudinal trends in use of bone mass measurement among older americans, 1999-2005
-
Curtis JR, Carbone L, Cheng H, et al. Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res. 2008;23(7):1061-1067.
-
(2008)
J Bone Miner Res
, vol.23
, Issue.7
, pp. 1061-1067
-
-
Curtis, J.R.1
Carbone, L.2
Cheng, H.3
-
51
-
-
33846226395
-
Adherence of academic geriatric practitioners to osteoporosis screening guidelines
-
McNally DN, Kenny AM, Smith JA. Adherence of academic geriatric practitioners to osteoporosis screening guidelines. Osteoporos Int. 2007;18(2):177-183.
-
(2007)
Osteoporos Int
, vol.18
, Issue.2
, pp. 177-183
-
-
McNally, D.N.1
Kenny, A.M.2
Smith, J.A.3
-
52
-
-
9444244524
-
The use of calcaneal ultrasound evaluation of bone mineral density in cognitively impaired seniors
-
Juby AG. The use of calcaneal ultrasound evaluation of bone mineral density in cognitively impaired seniors. J Am Med Dir Assoc. 2004;5(6):377-381.
-
(2004)
J Am Med Dir Assoc
, vol.5
, Issue.6
, pp. 377-381
-
-
Juby, A.G.1
-
53
-
-
42649144128
-
Quantitative ultrasound in the management of osteoporosis: The 2007 ISCD Official Positions
-
Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008;11:163-187.
-
(2008)
J Clin Densitom
, vol.11
, pp. 163-187
-
-
Krieg, M.A.1
Barkmann, R.2
Gonnelli, S.3
-
54
-
-
2942674531
-
Osteoporosis assessment strategies for male nursing home residents
-
Elliott ME, Drinka PJ, Krause P, Binkley NC, Mahoney JE. Osteoporosis assessment strategies for male nursing home residents. Maturitas. 2004;48(3):225-233.
-
(2004)
Maturitas
, vol.48
, Issue.3
, pp. 225-233
-
-
Elliott, M.E.1
Drinka, P.J.2
Krause, P.3
Binkley, N.C.4
Mahoney, J.E.5
-
55
-
-
0038350758
-
Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D
-
Elliott ME, Binkley NC, Carnes M, et al. Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy. 2003;23(6):702-710.
-
(2003)
Pharmacotherapy
, vol.23
, Issue.6
, pp. 702-710
-
-
Elliott, M.E.1
Binkley, N.C.2
Carnes, M.3
-
56
-
-
66349096712
-
-
FRAX WHO Fracture Risk Assessment Tool. University of Sheffield UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases.; c2008 [cited 2009 Jan 9]. Available from: http://www.shef.ac.uk/FRAX/.
-
FRAX WHO Fracture Risk Assessment Tool. University of Sheffield UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases.; c2008 [cited 2009 Jan 9]. Available from: http://www.shef.ac.uk/FRAX/.
-
-
-
-
57
-
-
0030716177
-
Treatment with alendronate prevents fractures in women at highest risk: Results from the Fracture Intervention Trial
-
Ensrud KE, Black DM, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med. 1997;157(22):2617-2624.
-
(1997)
Arch Intern Med
, vol.157
, Issue.22
, pp. 2617-2624
-
-
Ensrud, K.E.1
Black, D.M.2
Palermo, L.3
-
58
-
-
0035005348
-
Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention
-
Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc. 2001;49(5):664-672.
-
(2001)
J Am Geriatr Soc
, vol.49
, Issue.5
, pp. 664-672
-
-
-
59
-
-
34848906818
-
Quality indicators for falls and mobility problems in vulnerable elders
-
Chang JT, Ganz DA. Quality indicators for falls and mobility problems in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S327-S334.
-
(2007)
J Am Geriatr Soc
, vol.55
, Issue.SUPPL. 2
-
-
Chang, J.T.1
Ganz, D.A.2
-
60
-
-
34248574968
-
-
Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J Med. 2007;120(6):493 e1-e6.
-
Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J Med. 2007;120(6):493 e1-e6.
-
-
-
-
61
-
-
0037406769
-
Nonpharmacologic interventions. Exercise, fall prevention, and role of physical medicine
-
Sinaki M. Nonpharmacologic interventions. Exercise, fall prevention, and role of physical medicine. Clin Geriatr Med. 2003;19(2):337-359.
-
(2003)
Clin Geriatr Med
, vol.19
, Issue.2
, pp. 337-359
-
-
Sinaki, M.1
-
62
-
-
66349093791
-
Exercise for preventing and treating osteoporosis in postemenopausal women
-
Bonaiuti D SB, Iovine R, Negrini S, Robinson V, Kemper HC, Wells G, Tugwell P, Cranney A. Exercise for preventing and treating osteoporosis in postemenopausal women. Cochrane Database of Systematic Reviews; 2002(2).
-
Cochrane Database of Systematic Reviews
, vol.2002
, Issue.2
-
-
Bonaiuti, D.S.1
Iovine, R.2
Negrini, S.3
Robinson, V.4
Kemper, H.C.5
Wells, G.6
Tugwell, P.7
Cranney, A.8
-
63
-
-
34548269021
-
Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association
-
Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1435-1445.
-
(2007)
Med Sci Sports Exerc
, vol.39
, Issue.8
, pp. 1435-1445
-
-
Nelson, M.E.1
Rejeski, W.J.2
Blair, S.N.3
-
64
-
-
2142713080
-
Effect of Vitamin D on falls: A meta-analysis
-
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291(16): 1999-2006.
-
(2004)
JAMA
, vol.291
, Issue.16
, pp. 1999-2006
-
-
Bischoff-Ferrari, H.A.1
Dawson-Hughes, B.2
Willett, W.C.3
-
65
-
-
38849091377
-
Vitamin D supplementation to prevent falls In the elderly: Evidence and practical considerations
-
Fosnight SM, Zafirau WJ, Hazelett SE. Vitamin D supplementation to prevent falls In the elderly: evidence and practical considerations. Pharmacotherapy. 2008;28(2):225-234.
-
(2008)
Pharmacotherapy
, vol.28
, Issue.2
, pp. 225-234
-
-
Fosnight, S.M.1
Zafirau, W.J.2
Hazelett, S.E.3
-
66
-
-
29244461700
-
Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial
-
Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial.J Am Geriatr Soc. 2005;53(11):1881-1888.
-
(2005)
J Am Geriatr Soc
, vol.53
, Issue.11
, pp. 1881-1888
-
-
Flicker, L.1
MacInnis, R.J.2
Stein, M.S.3
-
67
-
-
33846513446
-
Impact of smoking cessation on bone mineral density in postmenopausal women
-
Oncken C, Prestwood K, Kleppinger A, Wang Y, Cooney J, Raisz L. Impact of smoking cessation on bone mineral density in postmenopausal women. J Womens Health. 2006;15(10):1141-1150.
-
(2006)
J Womens Health
, vol.15
, Issue.10
, pp. 1141-1150
-
-
Oncken, C.1
Prestwood, K.2
Kleppinger, A.3
Wang, Y.4
Cooney, J.5
Raisz, L.6
-
68
-
-
0033106426
-
Smoking, smoking cessation, and risk of hip fracture in women
-
Cornuz J, Feskanich D, Willett WC, Colditz GA. Smoking, smoking cessation, and risk of hip fracture in women. Am J Med. 1999;106(3):311-314.
-
(1999)
Am J Med
, vol.106
, Issue.3
, pp. 311-314
-
-
Cornuz, J.1
Feskanich, D.2
Willett, W.C.3
Colditz, G.A.4
-
69
-
-
24344441756
-
Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials
-
Sawka AM, Boulos P, Beattie K, et al. Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2005;16(12):1461-1474.
-
(2005)
Osteoporos Int
, vol.16
, Issue.12
, pp. 1461-1474
-
-
Sawka, A.M.1
Boulos, P.2
Beattie, K.3
-
70
-
-
34547167603
-
Efficacy of a hip protector to prevent hip fracture in nursing home residents: The HIP PRO randomized controlled trial
-
Kiel DP, Magaziner J, Zimmerman S, et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007;298(4):413-422.
-
(2007)
JAMA
, vol.298
, Issue.4
, pp. 413-422
-
-
Kiel, D.P.1
Magaziner, J.2
Zimmerman, S.3
-
71
-
-
21244436672
-
Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
-
O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118(7):778-781.
-
(2005)
Am J Med
, vol.118
, Issue.7
, pp. 778-781
-
-
O'Connell, M.B.1
Madden, D.M.2
Murray, A.M.3
Heaney, R.P.4
Kerzner, L.J.5
-
72
-
-
33845864487
-
Long-term proton pump inhibitor therapy and risk of hip fracture
-
Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24): 2947-2953.
-
(2006)
JAMA
, vol.296
, Issue.24
, pp. 2947-2953
-
-
Yang, Y.X.1
Lewis, J.D.2
Epstein, S.3
Metz, D.C.4
-
73
-
-
34548047185
-
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis
-
Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-666.
-
(2007)
Lancet
, vol.370
, Issue.9588
, pp. 657-666
-
-
Tang, B.M.P.1
Eslick, G.D.2
Nowson, C.3
Smith, C.4
Bensoussan, A.5
-
74
-
-
18244397439
-
Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials
-
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18): 2257-2264.
-
(2005)
JAMA
, vol.293
, Issue.18
, pp. 2257-2264
-
-
Bischoff-Ferrari, H.A.1
Willett, W.C.2
Wong, J.B.3
Giovannucci, E.4
Dietrich, T.5
Dawson-Hughes, B.6
-
75
-
-
30744449356
-
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
-
Avenell AGW, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database of Systematic Reviews; 2005(3).
-
Cochrane Database of Systematic Reviews
, vol.2005
, Issue.3
-
-
Avenell, A.G.W.1
Gillespie, L.D.2
O'Connell, D.L.3
-
76
-
-
34147164190
-
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: Evidence from a comparative metaanalysis of randomized controlled trials
-
Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-1423.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, Issue.4
, pp. 1415-1423
-
-
Boonen, S.1
Lips, P.2
Bouillon, R.3
Bischoff-Ferrari, H.A.4
Vanderschueren, D.5
Haentjens, P.6
-
77
-
-
33846569956
-
A higher dose of vitamin d reduces the risk of falls in nursing home residents: A randomized, multiple-dose study
-
Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55(2):234-239.
-
(2007)
J Am Geriatr Soc
, vol.55
, Issue.2
, pp. 234-239
-
-
Broe, K.E.1
Chen, T.C.2
Weinberg, J.3
Bischoff-Ferrari, H.A.4
Holick, M.F.5
Kiel, D.P.6
-
78
-
-
33748070519
-
Vitamin D supplementation and the prevention of fractures and falls: Results of a randomised trial in elderly people in residential accommodation
-
Law M, Withers H, Morris J, Anderson F. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing. 2006;35(5):482-486.
-
(2006)
Age Ageing
, vol.35
, Issue.5
, pp. 482-486
-
-
Law, M.1
Withers, H.2
Morris, J.3
Anderson, F.4
-
79
-
-
34247601023
-
Preventing fractures among older people living in institutional care: A pragmatic randomised double blind placebo controlled trial of vitamin D supplementation
-
Lyons RA, Johansen A, Brophy S, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int. 2007;18(6):811-818.
-
(2007)
Osteoporos Int
, vol.18
, Issue.6
, pp. 811-818
-
-
Lyons, R.A.1
Johansen, A.2
Brophy, S.3
-
80
-
-
66349088865
-
World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK
-
National Osteoporosis Guideline Group, cited 2009 Jan 9, Available from
-
National Osteoporosis Guideline Group. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK; 2008. [cited 2009 Jan 9]; Available from: http://www.shef.ac.uk/ NOGG/.
-
(2008)
Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
-
-
-
81
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
-
Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535-1541.
-
(1996)
Lancet
, vol.348
, Issue.9041
, pp. 1535-1541
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
-
82
-
-
66349124530
-
-
US Food and Drug Administration. Center for Drug Evaluation and Research. FDA Alert: Information on Bisphosphonates[created: 2008 Jan 7, updated 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm.
-
US Food and Drug Administration. Center for Drug Evaluation and Research. FDA Alert: Information on Bisphosphonates[created: 2008 Jan 7, updated 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm.
-
-
-
-
83
-
-
33646836925
-
Narrative review: Bisphosphonates and osteonecrosis of the jaws
-
Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144(10): 753-761.
-
(2006)
Ann Intern Med
, vol.144
, Issue.10
, pp. 753-761
-
-
Woo, S.B.1
Hellstein, J.W.2
Kalmar, J.R.3
-
84
-
-
33847413194
-
Bisphosphonate-induced osteonecrosis of the jaw
-
Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Bisphosphonate-induced osteonecrosis of the jaw. Ann Pharmacother. 2007;41(2):276-284.
-
(2007)
Ann Pharmacother
, vol.41
, Issue.2
, pp. 276-284
-
-
Krueger, C.D.1
West, P.M.2
Sargent, M.3
Lodolce, A.E.4
Pickard, A.S.5
-
85
-
-
66349093770
-
-
US Food and Drug Administration. Center for Drug Evaluation and Research. Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates [created: 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_ 200811.htm.
-
US Food and Drug Administration. Center for Drug Evaluation and Research. Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates [created: 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_ 200811.htm.
-
-
-
-
86
-
-
22844452550
-
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women
-
Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int. 2005;16(5):468-474.
-
(2005)
Osteoporos Int
, vol.16
, Issue.5
, pp. 468-474
-
-
Papapoulos, S.E.1
Quandt, S.A.2
Liberman, U.A.3
Hochberg, M.C.4
Thompson, D.E.5
-
87
-
-
12944291524
-
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
-
Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11(1):83-91.
-
(2000)
Osteoporos Int
, vol.11
, Issue.1
, pp. 83-91
-
-
Reginster, J.1
Minne, H.W.2
Sorensen, O.H.3
-
88
-
-
0035253489
-
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group
-
McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344(5):333-340.
-
(2001)
N Engl J Med
, vol.344
, Issue.5
, pp. 333-340
-
-
McClung, M.R.1
Geusens, P.2
Miller, P.D.3
-
89
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
-
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14): 1344-1352.
-
(1999)
JAMA
, vol.282
, Issue.14
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
-
90
-
-
4544262219
-
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
-
Chesnut IC, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19(8):1241-1249.
-
(2004)
J Bone Miner Res
, vol.19
, Issue.8
, pp. 1241-1249
-
-
Chesnut, I.C.1
Skag, A.2
Christiansen, C.3
-
91
-
-
33745034449
-
Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study
-
Delmas PD, Adami S, Strugala C, et al. Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum. 2006;54(6):1838-1846.
-
(2006)
Arthritis Rheum
, vol.54
, Issue.6
, pp. 1838-1846
-
-
Delmas, P.D.1
Adami, S.2
Strugala, C.3
-
92
-
-
35748967004
-
Zoledronic acid and clinical fractures and mortality after hip fracture
-
Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799-1809.
-
(2007)
N Engl J Med
, vol.357
, Issue.18
, pp. 1799-1809
-
-
Lyles, K.W.1
Colon-Emeric, C.S.2
Magaziner, J.S.3
-
93
-
-
34247866550
-
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
-
Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809-1822.
-
(2007)
N Engl J Med
, vol.356
, Issue.18
, pp. 1809-1822
-
-
Black, D.M.1
Delmas, P.D.2
Eastell, R.3
-
94
-
-
0033581212
-
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
-
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282(7):637-645.
-
(1999)
JAMA
, vol.282
, Issue.7
, pp. 637-645
-
-
Ettinger, B.1
Black, D.M.2
Mitlak, B.H.3
-
95
-
-
33745876266
-
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
-
Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006;355(2):125-137.
-
(2006)
N Engl J Med
, vol.355
, Issue.2
, pp. 125-137
-
-
Barrett-Connor, E.1
Mosca, L.2
Collins, P.3
-
96
-
-
33746197958
-
Osteoporosis treatment: Raloxifene (Evista) and stroke mortality
-
Wooltorton E. Osteoporosis treatment: raloxifene (Evista) and stroke mortality. CMAJ. 2006;175(2):147.
-
(2006)
CMAJ
, vol.175
, Issue.2
, pp. 147
-
-
Wooltorton, E.1
-
97
-
-
0033829969
-
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Group
-
Chesnut CH, 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med. 2000;109(4):267-276.
-
(2000)
Am J Med
, vol.109
, Issue.4
, pp. 267-276
-
-
Chesnut 3rd, C.H.1
Silverman, S.2
Andriano, K.3
-
98
-
-
25844438772
-
Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: A systematic review of randomized, controlled trials
-
Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int. 2005;16(10):1281-1290.
-
(2005)
Osteoporos Int
, vol.16
, Issue.10
, pp. 1281-1290
-
-
Knopp, J.A.1
Diner, B.M.2
Blitz, M.3
Lyritis, G.P.4
Rowe, B.H.5
-
99
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19): 1434-1441.
-
(2001)
N Engl J Med
, vol.344
, Issue.19
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
-
100
-
-
33947504500
-
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: A randomized trial
-
Greenspan SL, Bone HG, Ettinger MP, et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007;146(5):326-339.
-
(2007)
Ann Intern Med
, vol.146
, Issue.5
, pp. 326-339
-
-
Greenspan, S.L.1
Bone, H.G.2
Ettinger, M.P.3
-
101
-
-
9144233479
-
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
-
Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350(5):459-468.
-
(2004)
N Engl J Med
, vol.350
, Issue.5
, pp. 459-468
-
-
Meunier, P.J.1
Roux, C.2
Seeman, E.3
-
102
-
-
21044447888
-
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
-
Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90(5):2816-2822.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.5
, pp. 2816-2822
-
-
Reginster, J.Y.1
Seeman, E.2
De Vernejoul, M.C.3
-
103
-
-
33750105854
-
Strontium ranelate for preventing and treating postmenopausal osteoporosis
-
CD005326
-
O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY. Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev. 2006;(4):CD005326.
-
(2006)
Cochrane Database Syst Rev
, Issue.4
-
-
O'Donnell, S.1
Cranney, A.2
Wells, G.A.3
Adachi, J.D.4
Reginster, J.Y.5
-
104
-
-
1842867053
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial
-
Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291(14):1701-1712.
-
(2004)
JAMA
, vol.291
, Issue.14
, pp. 1701-1712
-
-
Anderson, G.L.1
Limacher, M.2
Assaf, A.R.3
-
105
-
-
0141705375
-
Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial
-
Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290(13):1729-1738.
-
(2003)
JAMA
, vol.290
, Issue.13
, pp. 1729-1738
-
-
Cauley, J.A.1
Robbins, J.2
Chen, Z.3
-
106
-
-
66349091128
-
-
Arias, E. National Vitals Statistic Report: United States Life Tables, 2003. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [created 2006 April 16, updated 2007 March 28; cited 2009 Jan 9] Available from: http://www.cdc.gov/nchs/data/statab/lewk3_2003.pdf.
-
Arias, E. National Vitals Statistic Report: United States Life Tables, 2003. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [created 2006 April 16, updated 2007 March 28; cited 2009 Jan 9] Available from: http://www.cdc.gov/nchs/data/statab/lewk3_2003.pdf.
-
-
-
-
107
-
-
0037182042
-
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
-
Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med. 2002;162(10):1140-1143.
-
(2002)
Arch Intern Med
, vol.162
, Issue.10
, pp. 1140-1143
-
-
Maricic, M.1
Adachi, J.D.2
Sarkar, S.3
Wu, W.4
Wong, M.5
Harper, K.D.6
-
108
-
-
11144354206
-
Efficacy of risedronate on clinical vertebral fractures within six months
-
Roux C, Seeman E, Eastell R, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004;20(4):433-439.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.4
, pp. 433-439
-
-
Roux, C.1
Seeman, E.2
Eastell, R.3
-
109
-
-
19044391760
-
Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures
-
Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005;20(6):971-976.
-
(2005)
J Bone Miner Res
, vol.20
, Issue.6
, pp. 971-976
-
-
Hochberg, M.C.1
Thompson, D.E.2
Black, D.M.3
-
110
-
-
4644346180
-
Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest old
-
Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc. 2004;52(11):1832-1839.
-
(2004)
J Am Geriatr Soc
, vol.52
, Issue.11
, pp. 1832-1839
-
-
Boonen, S.1
McClung, M.R.2
Eastell, R.3
El-Hajj Fuleihan, G.4
Barton, I.P.5
Delmas, P.6
-
111
-
-
66349119371
-
-
Cauley JA, Black D, Boonen SR, et al. Effect of Zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT. Osteoporos Int. 2007;18 (Suppl 2):S232. Abstract from the Seventh International Symposium on Osteoporosis: Translating Research into Clinical Practice. #P8.32.
-
Cauley JA, Black D, Boonen SR, et al. Effect of Zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT. Osteoporos Int. 2007;18 (Suppl 2):S232. Abstract from the Seventh International Symposium on Osteoporosis: Translating Research into Clinical Practice. #P8.32.
-
-
-
-
112
-
-
33744973067
-
Safety and efficacy of teriparatide in elderly women with established osteoporosis: Bone anabolic therapy from a geriatric perspective
-
Boonen S, Marin F, Mellstrom D, et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc. 2006;54(5):782-789.
-
(2006)
J Am Geriatr Soc
, vol.54
, Issue.5
, pp. 782-789
-
-
Boonen, S.1
Marin, F.2
Mellstrom, D.3
-
113
-
-
0037216436
-
The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
-
Marcus R, Wang O, Satterwhite J, Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res. 2003;18(1):18-23.
-
(2003)
J Bone Miner Res
, vol.18
, Issue.1
, pp. 18-23
-
-
Marcus, R.1
Wang, O.2
Satterwhite, J.3
Mitlak, B.4
-
114
-
-
33745494818
-
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older
-
Seeman E, Vellas B, Benhamou C, et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res. 2006;21(7):1113-1120.
-
(2006)
J Bone Miner Res
, vol.21
, Issue.7
, pp. 1113-1120
-
-
Seeman, E.1
Vellas, B.2
Benhamou, C.3
-
115
-
-
0037150130
-
Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial
-
Greenspan SL, Schneider DL, McClung MR, et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Annals of Intern Med. 2002;136(10): 742-746.
-
(2002)
Annals of Intern Med
, vol.136
, Issue.10
, pp. 742-746
-
-
Greenspan, S.L.1
Schneider, D.L.2
McClung, M.R.3
-
116
-
-
0024309856
-
Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures
-
Pun KK, Chan LW. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther. 1989;11(2):205-209.
-
(1989)
Clin Ther
, vol.11
, Issue.2
, pp. 205-209
-
-
Pun, K.K.1
Chan, L.W.2
-
117
-
-
0031255490
-
Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study
-
Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl. 1997;275:112-114.
-
(1997)
Acta Orthop Scand Suppl
, vol.275
, pp. 112-114
-
-
Lyritis, G.P.1
Paspati, I.2
Karachalios, T.3
Ioakimidis, D.4
Skarantavos, G.5
Lyritis, P.G.6
-
118
-
-
0037214255
-
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
-
Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res. 2003;18(1):9-17.
-
(2003)
J Bone Miner Res
, vol.18
, Issue.1
, pp. 9-17
-
-
Orwoll, E.S.1
Scheele, W.H.2
Paul, S.3
-
119
-
-
23744484933
-
Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke
-
Sato Y, Iwamoto J, Kanoko T, Satoh K. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med. 2005;165(15):1743-1748.
-
(2005)
Arch Intern Med
, vol.165
, Issue.15
, pp. 1743-1748
-
-
Sato, Y.1
Iwamoto, J.2
Kanoko, T.3
Satoh, K.4
-
120
-
-
34147108671
-
Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease
-
Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68(12):911-915.
-
(2007)
Neurology
, vol.68
, Issue.12
, pp. 911-915
-
-
Sato, Y.1
Honda, Y.2
Iwamoto, J.3
-
121
-
-
33644616548
-
Efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 1-year study
-
Ringe JD, Faber H, Farahmand P, Dorst A. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int. 2006;26(5):427-431.
-
(2006)
Rheumatol Int
, vol.26
, Issue.5
, pp. 427-431
-
-
Ringe, J.D.1
Faber, H.2
Farahmand, P.3
Dorst, A.4
-
122
-
-
0141796739
-
The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
-
Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003;349(13):1216-1226.
-
(2003)
N Engl J Med
, vol.349
, Issue.13
, pp. 1216-1226
-
-
Finkelstein, J.S.1
Hayes, A.2
Hunzelman, J.L.3
Wyland, J.J.4
Lee, H.5
Neer, R.M.6
-
123
-
-
0034739277
-
Alendronate for the treatment of osteoporosis in men
-
Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343(9):604-610.
-
(2000)
N Engl J Med
, vol.343
, Issue.9
, pp. 604-610
-
-
Orwoll, E.1
Ettinger, M.2
Weiss, S.3
-
124
-
-
26444539825
-
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age
-
Ettinger MP, Felsenberg D, Harris ST, et al. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age. J Rheumatol. 2005;32(10):1968-1974.
-
(2005)
J Rheumatol
, vol.32
, Issue.10
, pp. 1968-1974
-
-
Ettinger, M.P.1
Felsenberg, D.2
Harris, S.T.3
-
125
-
-
33846899271
-
Compliance with osteoporosis drug therapy and risk of fracture
-
Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int. 2007;18(3):271-277.
-
(2007)
Osteoporos Int
, vol.18
, Issue.3
, pp. 271-277
-
-
Weycker, D.1
Macarios, D.2
Edelsberg, J.3
Oster, G.4
-
126
-
-
44949126427
-
Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
-
Blouin J, Dragomir A, Moride Y, Ste-Marie LG, Fernandes JC, Perreault S. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol. 2008;66(1):117-127.
-
(2008)
Br J Clin Pharmacol
, vol.66
, Issue.1
, pp. 117-127
-
-
Blouin, J.1
Dragomir, A.2
Moride, Y.3
Ste-Marie, L.G.4
Fernandes, J.C.5
Perreault, S.6
-
127
-
-
33746821808
-
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases
-
Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013-1022.
-
(2006)
Mayo Clin Proc
, vol.81
, Issue.8
, pp. 1013-1022
-
-
Siris, E.S.1
Harris, S.T.2
Rosen, C.J.3
-
128
-
-
42249109858
-
Use of bisphosphonates among women and risk of atrial fibrillation and flutter: Population based case-control study
-
Sorensen HT, Christensen S, Mehnert F, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ. 2008;336(7648):813-816.
-
(2008)
BMJ
, vol.336
, Issue.7648
, pp. 813-816
-
-
Sorensen, H.T.1
Christensen, S.2
Mehnert, F.3
-
130
-
-
42949145038
-
Use of alendronate and risk of incident atrial fibrillation in women
-
Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med. 2008;168(8):826-831.
-
(2008)
Arch Intern Med
, vol.168
, Issue.8
, pp. 826-831
-
-
Heckbert, S.R.1
Li, G.2
Cummings, S.R.3
Smith, N.L.4
Psaty, B.M.5
-
131
-
-
33745249570
-
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
-
Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295(23):2727-2741.
-
(2006)
JAMA
, vol.295
, Issue.23
, pp. 2727-2741
-
-
Vogel, V.G.1
Costantino, J.P.2
Wickerham, D.L.3
-
132
-
-
0036235019
-
Prevalence of low glomerular fi ltration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)
-
Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular fi ltration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13(5):1338-1349.
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.5
, pp. 1338-1349
-
-
Clase, C.M.1
Garg, A.X.2
Kiberd, B.A.3
-
133
-
-
33846527154
-
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: The Rancho Bernardo study
-
Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res. 2007;22(2):203-210.
-
(2007)
J Bone Miner Res
, vol.22
, Issue.2
, pp. 203-210
-
-
Jassal, S.K.1
von Muhlen, D.2
Barrett-Connor, E.3
-
134
-
-
28144453342
-
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials
-
Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005;20(12):2105-2115.
-
(2005)
J Bone Miner Res
, vol.20
, Issue.12
, pp. 2105-2115
-
-
Miller, P.D.1
Roux, C.2
Boonen, S.3
Barton, I.P.4
Dunlap, L.E.5
Burgio, D.E.6
-
135
-
-
33845370793
-
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
-
Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int. 2007;18(1):59-68.
-
(2007)
Osteoporos Int
, vol.18
, Issue.1
, pp. 59-68
-
-
Miller, P.D.1
Schwartz, E.N.2
Chen, P.3
Misurski, D.A.4
Krege, J.H.5
-
136
-
-
34249653663
-
Alendronate treatment in women with normal to severely impaired renal function: An analysis of the fracture intervention trial
-
Jamal SA, Bauer DC, Ensrud KE, et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res. 2007;22(4): 503-508.
-
(2007)
J Bone Miner Res
, vol.22
, Issue.4
, pp. 503-508
-
-
Jamal, S.A.1
Bauer, D.C.2
Ensrud, K.E.3
-
137
-
-
48149088817
-
The effect of raloxifene treatment in postmenopausal women with CKD
-
Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE. The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol. 2008;19(7):1430-1438.
-
(2008)
J Am Soc Nephrol
, vol.19
, Issue.7
, pp. 1430-1438
-
-
Ishani, A.1
Blackwell, T.2
Jamal, S.A.3
Cummings, S.R.4
Ensrud, K.E.5
|